Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$298,100.00
Jun 10, 2024
Academia
Machine learning for Linking Lipidomics and Metabolomics with Clinical Measures for design of multimodal diagnostic models
1022500
Linking these data through hybrid machine learning and knowledge driven methods with molecular data provided by metabolomics and lipidomics is expected to lead to tangible clinical solutions in design of novel diagnostic, theragnostic and therapy avenues. Design of analytical AI and ML methods linking metabolome and lipidome with for example MRI or EEG is expected to provide an avenue for the understanding and design of innovative diagnostic and therapeutic modalities.
$15,000.00
Jun 10, 2024
For-profit organization
Develop digital adoption plan
$2,691.00
Jun 5, 2024
Not-for-profit organization or charity
Welcome Project workshops and activities
GC-2558
This grant supports the Power To Be Society’s development and delivery of Welcome Project training and ongoing collaboration in Learn-to Camp workshops and activities.
$320,600.00
Jun 3, 2024
For-profit organization
UKRI Biomanufacturing - 10101911 Novel VVP Platform - Next generation high-yield producer platform for cell and gene therapy viral vectors and other complex biologics
1019854
This project focuses on increasing viral vector productivity at least 50-100 folds higher by the genetic modification of the 293-cell line targeting genes with crucial role in viral vector production and quality.
$15,000.00
May 30, 2024
For-profit organization
Develop digital adoption plan
$15,000.00
May 27, 2024
For-profit organization
Develop digital adoption plan
$12,180.00
May 27, 2024
For-profit organization
Skin Focus Regenerative Therapy
019718675
Through the application of national and local priorities, the CSJ program seeks to provide youth, particularly those who face barriers to employment with access to work opportunities. Funded employers must demonstrate that they are providing quality work experiences for youth that provide opportunities to develop and improve their skills.
$15,000.00
May 7, 2024
For-profit organization
Develop digital adoption plan
$304,720.00
May 1, 2024
For-profit organization
UKRI Biomanufacturing - 10100745 - Viral Enhancers - Development of small molecule formulations for enhanced production of AAV
1019804
As part of the international consortium project "Viral Enhancers - Development of small molecule formulations for enhanced production of AAV", this project will focus on developing and demonstrating at scale small molecule formulation(s) which increase the yield of next-generation gene therapies. Development of such technologies will enable faster clinical and commercial development of life saving technologies while simultaneously improving patient access through reduction of cost per dose.
$200,000.00
May 1, 2024
For-profit organization
Development of degradable Cryoprotective Agents for Cell-based Therapies
1020999
Non-cell permeating microgels are developed to promote cryopreservation with limited or no use of DMSO. This project aims to develop degradable microgels that are easy to separate from cell suspensions post-thawing. The microgels are being developed to work with a wide variety of cells and cell clusters.